International real estate adviser, Savills, has reported a 10% boost in revenue in 2019, driven by strong performance in its 'less transactional' business lines....
Pharma giant AstraZeneca said its trial of a potential new medicine to treat patients with sensitive relapsed ovarian cancer had failed to meet its primary...